Posted in | News | Uranium | Lithium

Clean Commodities Acquires Two Sisters Creek Project Located Near British Columbia

Clean Commodities Corp. ("Clean Commodities" or the "Corporation" or "CLE") is pleased to announce the acquisition of the Two Sisters Creek Project, located near Wells, British Columbia.

"The Two Sisters Creek Project provides our shareholders with early-mover optionality to the Wells gold camp and recent exploration results in the area. Although we are primarily focused on our significant uranium and lithium assets, the chance to participate in the Wells gold camp was a project opportunity that we believe presents immediate accretive value for our fellow shareholders. As such, we were very pleased to acquire the project and look forward to defining our exploration plans there moving forward," stated Ryan Kalt, CEO of the Corporation.

About The Two Sisters Creek Project

The Two Sisters Creek Project covers a significant section of its namesake, the Two Sisters Creek, and is approximately 1,770 acres in size. The claim block borders tenure held by Barkerville Gold Mines Ltd. and is also adjacent to the primary mineral tenure block of the Gold Mountain Project announced by Spearmint Resources Inc. by news release also dated April 18 2017. The adjacent Gold Mountain 2 claim held by Spearmint Resources Inc., claim 1051449, is 1,149 acres in size as compared to the contiguous 1,770 acre Two Sisters claim block held by CLE.

A map of the project may be viewed at: https://www.cleancommodities.com/twosisterscreek

The Two Sisters Creek Project was acquired by the Corporation through staking.

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.